Multidimensional value analysis of standardized and graded pharmaceutical services in hospitalized patients with chronic airway diseases
- VernacularTitle:标准化分级药学监护服务在慢性气道疾病住院患者中的多维价值分析
- Author:
Yufei LIAN
1
;
Xuejia QIU
1
;
Jingnan YANG
1
;
Lingzhi FANG
1
;
Yupeng YANG
2
;
Hongtao LIU
3
;
Zhanjun DONG
1
Author Information
1. Dept. of Pharmacy，Hebei General Hospital，Shijiazhuang 050051，China
2. Dept. of Stomatology，Hebei General Hospital，Shijiazhuang 050051，China
3. Dept. of Pharmacy，the First Hospital of Hebei Medical University，Shijiazhuang 050031，China
- Publication Type:Journal Article
- Keywords:
cough and asthma pharmaceutical services
- From:
China Pharmacy
2024;35(19):2404-2410
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide reference for constructing scientific and reasonable pharmaceutical service mode for hospitalized patients with chronic airway diseases. METHODS From October 2023 to March 2024， 250 patients with chronic obstructive pulmonary disease and acute exacerbation of asthma who were hospitalized in the respiratory department of Hebei General Hospital and received pharmaceutical care （PC） were randomly divided into control group （125 cases） and observation group （125 cases）. The control group received general pharmaceutical services throughout their hospitalization， while the observation group received standardized and graded pharmaceutical services throughout their hospitalization. The differences in clinical value indicators， humanistic value indicators， and quality management indicators were compared among different PC service models. RESULTS Among clinical value evaluation indicators， the observation group had better achievement rate of disease treatment goals， correct use score of inhalation devices， the incidence of adverse drug reactions， and the number of drug-related problems solved than the control group （P＜0.05）. Among the humanistic evaluation indicators， compared with the control group， the observation group had better medication compliance scores， pharmacist intervention success rates， and patient satisfaction scores （P＜0.05）. Among quality management evaluation indicators， the proportion of drug costs， the proportion of intravenous medication， the use rate of antibiotics， the intensity of antibiotic use， and the number of pharmaceutical services in the observation group were significantly better than the control group （P＜0.05）. CONCLUSIONS Standardized and graded pharmaceutical care services have improved the efficiency of pharmacists and service effectiveness， making it a new pharmaceutical service model worth promoting.
